Magnesium Sulfate Injection, USP
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 6103881 | A. Magnesium Sulfate Injection, USP | - Recalling Firm
- Pharmaceutical Partners of Canada Inc.
- Suite 200, 45 Vogell Road
- Richmond Hill
- L4B 3P6
- Ontario
- CANADA
- Marketing Authorization Holder
- Pharmaceutical Partners of Canada Inc.
- Suite 200, 45 Vogell Road
- Richmond Hill
- L4B 3P6
- Ontario
- CANADA
| Solution | DIN 02139499 | 500 mg/mL |
Recalled Products
-
Magnesium Sulfate Injection, USP
Glass particulates discovered during inspection of retention samples (1 of 34 vials).
Wholesalers and hospitals across Canada.